Auditor Firm ID

[Table of Contents](#i43d04c9d26874e33802bdf64c458414a_7)The following table presents information regarding our equity compensation plans as of December 31, 2021:

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Securities To be Issued Upon Exercise of Outstanding Options, Warrants and Rights |  | Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a)) |
|  | (a) |  | (b) | (c) |
| Equity compensation plans approved by security holders | 29,954,073  |  | a | $ | 23.74  |  | 30,713,851  |  |
| Equity compensation plans not approved by security holders | 157,545  |  | b | $ | 27.00  |  | —  |  |
|    Total | 30,111,618  |  |  | $ | 23.76  |  | 30,713,851  |  |

  
a.Includes shares of our common stock issuable upon the vesting of 3,338,781 restricted stock units (RSUs) and 3,875,625 performance share units at maximum performance levels, and the termination of deferrals with respect to 1,197,900 RSUs that were vested as of December 31, 2021. These awards are not reflected in column (b) because they do not have an exercise price. The number of securities to be issued in column (a) does not include RSUs that are payable solely in cash. b.Represents securities to be issued under awards assumed in our acquisition of McMoRan Exploration Co. and includes shares issuable upon the termination of deferrals with respect to 13,500 RSUs that were vested as of December 31, 2021, which awards are not reflected in column (b) because they do not have an exercise price.  
Item 13.  Certain Relationships and Related Transactions, and Director Independence.  
The information set forth under the captions “Certain Transactions” and “Board and Committee Independence; Audit Committee Financial Experts” of our definitive proxy statement to be filed with the SEC, relating to our 2022 annual meeting of stockholders, is incorporated herein by reference.  
Item 14.  Principal Accounting Fees and Services.  
The information set forth under the caption “Independent Registered Public Accounting Firm” of our definitive proxy statement to be filed with the SEC (including fees billed to us by Ernst & Young, PCAOB ID No. 42), relating to our 2022 annual meeting of stockholders, is incorporated herein by reference..PART IV  
Item 15.  Exhibits, Financial Statement Schedules.  
(a)(1).                      Financial Statements.  
The consolidated statements of operations, comprehensive income (loss), cash flows and equity, and the consolidated balance sheets are included as part of Item 8. “Financial Statements and Supplementary Data.”  
(a)(2).                      Financial Statement Schedules.  
The following financial statement schedule is presented below.   
    Schedule II - Valuation and Qualifying Accounts  
Schedules other than the one above have been omitted since they are either not required, not applicable or the required information is included in the financial statements or notes thereto.  
175
